Yifeng He - Publications

Auxiliary liver transplantation using otherwise-discarded liver allograft combined with associating liver partition and portal vein ligation for staged hepatectomy for unresectable colorectal liver metastases.

Journal: Hepatobiliary surgery and nutrition

Published: June 05, 2025

Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study.

Journal: The Lancet. Oncology

Published: April 29, 2025

Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 11, 2025

First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study.

Journal: Signal transduction and targeted therapy

Published: February 10, 2025

p16INK4A flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.

Journal: Clinical and translational medicine

Published: August 30, 2022

Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic.

Journal: Hepatobiliary surgery and nutrition

Published: July 31, 2022

Role of Surgery in the Management of Liver Metastases From Gastrointestinal Stromal Tumors.

Journal: Frontiers in oncology

Published: March 24, 2022

Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis.

Journal: Frontiers in oncology

Published: May 13, 2021

Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.

Journal: European radiology

Published: November 20, 2018

CA125 over-release behavior following a 75-g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer.

Journal: International journal of cancer

Published: June 13, 2018

Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer.

Journal: Journal of translational medicine

Published: February 01, 2018

Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.

Journal: The Journal of international medical research

Published: December 15, 2017